TY - JOUR
T1 - Role of extensive diagnostic workup in young athletes and nonathletes with complex ventricular arrhythmias
AU - Narducci, Maria Lucia
AU - Pelargonio, Gemma
AU - La Rosa, Giulio
AU - Inzani, Frediano
AU - D'Amati, Giulia
AU - Novelli, Valeria
AU - Marano, Riccardo
AU - Perna, Francesco
AU - Bencardino, Gianluigi
AU - Pinnacchio, Gaetano
AU - Genuardi, Maurizio
AU - Cammarano, Michela
AU - Palmieri, Vincenzo
AU - Zeppilli, Paolo
AU - Crea, Filippo
PY - 2020
Y1 - 2020
N2 - Background: Ventricular arrhythmias (VAs) are the most common cause of death in athletes. The differences in the electroanatomic substrate in athletes and nonathletes with complex VA are unknown. Objective: The purpose of this study was to compare the electroanatomic substrate of complex VA in athletes vs nonathletes. Methods: The study prospectively enrolled young athletes and nonathletes with VA. Patients underwent 2-dimensional echocardiography, cardiac magnetic resonance (CMR) imaging, coronary angiography, 3-dimensional electroanatomic mapping (3D-EAM), and 3D-EAM–guided endomyocardial biopsy (EMB). Follow-up included 24-hour electrocardiographic Holter or implantable cardioverter-defibrillator/loop recorder interrogation for VA recurrence. Results: Thirty-three patients were enrolled: 18 competitive athletes (56%) and 15 nonathletes (44%). Left ventricular and right ventricular (RV) findings by echocardiography and CMR did not show structural disease. Nine athletes (50%) were asymptomatic compared to 1 nonathlete (7%; P <.05). Unifocal origin of VA was reported in 14 athletes (93%) and 17 nonathletes (94%). Athletes showed a larger RV unipolar than bipolar scar (18 ± 17 cm2 vs 3 ± 3.8 cm2; P = .04). Diagnostic yield of EMB was 50% in athletes and 40% in nonathletes. Among athletes, the final diagnosis was myocarditis in 2, arrhythmogenic ventricular right cardiomyopathy in 1, and focal replacement fibrosis in 1. Among nonathletes, EMB revealed focal replacement fibrosis in 4 cases. At median follow-up of 18.7 months, Kaplan-Meier curves showed lower VA recurrence in detrained athletes than nonathletes (53% vs 6%; P = .02). Conclusion: This study showed the need for extensive diagnostic workup in apparently healthy young patients with complex VA in order to characterize concealed cardiomyopathies.
AB - Background: Ventricular arrhythmias (VAs) are the most common cause of death in athletes. The differences in the electroanatomic substrate in athletes and nonathletes with complex VA are unknown. Objective: The purpose of this study was to compare the electroanatomic substrate of complex VA in athletes vs nonathletes. Methods: The study prospectively enrolled young athletes and nonathletes with VA. Patients underwent 2-dimensional echocardiography, cardiac magnetic resonance (CMR) imaging, coronary angiography, 3-dimensional electroanatomic mapping (3D-EAM), and 3D-EAM–guided endomyocardial biopsy (EMB). Follow-up included 24-hour electrocardiographic Holter or implantable cardioverter-defibrillator/loop recorder interrogation for VA recurrence. Results: Thirty-three patients were enrolled: 18 competitive athletes (56%) and 15 nonathletes (44%). Left ventricular and right ventricular (RV) findings by echocardiography and CMR did not show structural disease. Nine athletes (50%) were asymptomatic compared to 1 nonathlete (7%; P <.05). Unifocal origin of VA was reported in 14 athletes (93%) and 17 nonathletes (94%). Athletes showed a larger RV unipolar than bipolar scar (18 ± 17 cm2 vs 3 ± 3.8 cm2; P = .04). Diagnostic yield of EMB was 50% in athletes and 40% in nonathletes. Among athletes, the final diagnosis was myocarditis in 2, arrhythmogenic ventricular right cardiomyopathy in 1, and focal replacement fibrosis in 1. Among nonathletes, EMB revealed focal replacement fibrosis in 4 cases. At median follow-up of 18.7 months, Kaplan-Meier curves showed lower VA recurrence in detrained athletes than nonathletes (53% vs 6%; P = .02). Conclusion: This study showed the need for extensive diagnostic workup in apparently healthy young patients with complex VA in order to characterize concealed cardiomyopathies.
KW - 3D-EAM guided endomyocardial biopsy
KW - Athletes
KW - Innovative biotechnology
KW - Personalized medicine
KW - Ventricular arrhythmia
KW - 3D-EAM guided endomyocardial biopsy
KW - Athletes
KW - Innovative biotechnology
KW - Personalized medicine
KW - Ventricular arrhythmia
UR - http://hdl.handle.net/10807/151436
U2 - 10.1016/j.hrthm.2019.08.022
DO - 10.1016/j.hrthm.2019.08.022
M3 - Article
SN - 1547-5271
VL - 17
SP - 230
EP - 237
JO - Heart Rhythm
JF - Heart Rhythm
ER -